Harrow has announced the expansion of its Vevye Access for All (VAFA) program, now extending eligibi...

Bayer has submitted an application to the European Medicines Agency (EMA) to expand the therapeutic ...

Opus Genetics has reported new 1-month clinical data from the first pediatric patients treated with ...

Tenpoint Therapeutics, a clinical-stage biotechnology company, has announced the submission of a New...

Santen Pharmaceutical has received approval from China’s National Medical Products Administration (N...

Orasis Pharmaceuticals has announced the U.S. availability of its novel corrective eye drop, Qlosi (...

Nordic Pharma, a subsidiary of Nordic Group B.V., has announced that its innovative canalicular gel,...

Avisi Technologies has announced encouraging 6-month interim data from its ongoing VITA trial, showc...

Atsena Therapeutics has successfully closed an oversubscribed $150 million Series C financing round ...

The U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) to Aldeyra T...